Enhanced induction of interleukin-12(p40) secretion by human macrophages infected with Mycobacterium avium complex isolates from disseminated infection in AIDS patients

Journal of Infectious Diseases

Volumn 178, Issue 4, 1998, Pages 1209-1212

  Von Grünberg, Philipp W R ^a   Plum, Georg ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL GROWTH; CYTOKINE RELEASE; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MACROPHAGE; MYCOBACTERIUM INTRACELLULARE AVIUM; PATHOGENICITY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031706649     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515687     Document Type: Article

References (15)

1. Falkinham JO. Epidemiology of infection by nonluberculous mycobacteria. Clin Microbiol Rev 1996;9:177-215.
2. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-8.
3. Inderlied CB, Kemper CA, Bermudez LEM. The Mycobacterium avium complex. Clin Microbiol Rev 1993;6:266-310.
4. Castro AG, Silva RA, Appelberg R. Endogenously produced IL-12 is required for the induction of protective T-cells during Mycobacterium avium infection in mice. J Immunol 1995;155:2013-9.
5. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991;49:380-7.
6. Furney SK, Skinner PS, Roberts AD, Appelberg R, Orme IM. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect Immun 1992;60:4410-3.
7. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev 1997;10:611-36.
8. Ling P, Gately MK, Gubler U, et al. Human IL-12 p40 binds to the IL-12 receptor, but does not mediate biologic activity. J Immunol 1995;154:116-27.
9. Mattner F, Ozmen L, Podlaski FJ, et al. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12 - dependent shock but not from tumor necrosis factor-α-dependent shock. Infect Immun 1997;65:4734-7.
10. Chougnet C, Wynn TH, Clerici M, et al. Molecular analysis of decreased Interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996;174:46-53.
11. Crowle AJ, Tsang AY, Vatter AE, May MH. Comparison of 15 laboratory and patient-derived isolates of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol 1986;24:812-21.
12. Plum G, Clark Curtiss JE. Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages. Infect Immun 1994;62:476-83.
13. Plum G, Brenden M, Clark-Curtiss JE, Pulverer G. Cloning, sequencing, and expression of the mig gene of Mycobacterium avium, which codes for a secreted macrophage-induced protein. Infect Immun 1997;65:4548-57.
14. Frucht DM, Holland SM. Defective monocyte costimulation for IFN-γ production in familial disseminated Mycobacterium avium complex infection. J Immunol 1996;157:411-6.
15. Gazzinelli RT, Shukal B, Stevens R, et al. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 1995;155:1565-74.